These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3669759)

  • 1. A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomy.
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Leukemia; 1987 Apr; 1(4):337-40. PubMed ID: 3669759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hairy cell leukemia: bone marrow changes following splenectomy and alpha-interferon therapy.
    Pangalis GA; Kittas C; Viniou N; Kokkinou S; Variamis H; Paizis P; Melanthiou F; Fessas P
    Leukemia; 1987 Apr; 1(4):343-6. PubMed ID: 3669761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
    Damasio EE; Frassoldati A
    Leuk Lymphoma; 1994; 14 Suppl 1():95-8. PubMed ID: 7820061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of alpha-interferon in the treatment of hairy-cell leukemia].
    Pagnucco G; Castelli G; Lazzarino M; Bernasconi C
    Haematologica; 1990; 75 Suppl 4():56-67. PubMed ID: 2074056
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of treating 53 hairy cell leukemia patients with alpha-interferon.
    Flandrin G; Castaigne S; Sigaux F; Degos L
    Leukemia; 1987 Apr; 1(4):326-8. PubMed ID: 3669755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
    Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
    Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
    Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
    Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of recombinant interferon alpha-2 in 34 patients with hairy cell leukemia. Effect of splenectomy and dosage reduction results of therapy].
    Frey B; Hofmann V; Cavalli F; Fehr J; Kroner T; Nesthus I; Schwarzmeier J
    Schweiz Med Wochenschr; 1988 Oct; 118(41):1468-75. PubMed ID: 3238389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
    Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
    Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of interferon in the treatment of hairy cell leukemia.
    Ratain MJ; Vardiman JW; Golomb HM
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
    Gotić M; Rolović Z; Vuković S; Elezović I; Tomić D
    Srp Arh Celok Lek; 1990; 118(7-8):277-84. PubMed ID: 2097776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hairy cell leukaemia with recombinant alpha-interferon.
    Bezwoda WR; Hesdorffer CS; Dansey RD; Lewis D
    S Afr Med J; 1987 Nov; 72(10):661-2. PubMed ID: 3686262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lymphoblastoid interferon for hairy cell leukemia: results from the Italian Cooperative Group.
    Damasio EE; Bernasconi C; Castoldi GL; Chisesi T; Federico M; Lamparelli T; Lauria F; Pagnucco G; Resegoti L; Rossi E
    Leukemia; 1987 Apr; 1(4):331-3. PubMed ID: 3669757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
    Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
    Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The UCLA experience with type I interferons in hairy cell leukemia.
    Glaspy JA; Jacobs AD; Golde DW
    Leukemia; 1987 Apr; 1(4):323-6. PubMed ID: 3312839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
    Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hairy cell leukemia. Current management.
    Doane LL; Ratain MJ; Golomb HM
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):489-502. PubMed ID: 2182604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.